Scarica l'app Stockscreener
13.33
0.38%
0.05
Precedente Chiudi:
$13.28
Aprire:
$13.3317
Volume 24 ore:
320
Relative Volume:
0.01
Capitalizzazione di mercato:
$64.48M
Reddito:
$2.61M
Utile/perdita netta:
$1.69M
Rapporto P/E:
44.39
EPS:
0.3003
Flusso di cassa netto:
-
1 W Prestazione:
+3.90%
1M Prestazione:
+12.21%
6M Prestazione:
+67.04%
1 anno Prestazione:
+46.00%
Intervallo 1D:
$13.33
$13.33
Intervallo di 1 settimana:
$12.52
$13.33
Portata 52W:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Nome
Daxor Corporation
Settore
Industria
Telefono
212-330-8500
Indirizzo
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Confronta DXR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.33 | 66.19M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
458.82 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
190.22 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
268.65 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.31 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
276.64 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-16 | Iniziato | Ascendiant Capital Markets | Buy |
Daxor Corporation Borsa (DXR) Ultime notizie
Daxor Corporation to Participate in Exclusive Maxim Growth Summit Featuring 40 Promising Healthcare Companies - Quiver Quantitative
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit - GlobeNewswire
Why analysts raise outlook for Daxor Corporation (DX5) stock2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Will Daxor Corporation (DX5) stock extend growth storyJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Will Daxor Corporation (DX5) stock outperform benchmarksJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Can technical indicators confirm Daxor Corporation’s reversalWeekly Trade Report & Detailed Earnings Play Strategies - newser.com
How Daxor Corporation (DX5) stock behaves under inflation pressure2025 Historical Comparison & Fast Entry High Yield Tips - nchmf.gov.vn
How strong is Daxor Corporation (DX5) stock earnings growthWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Is Daxor Corporation (DX5) stock attractive for dividend growthMarket Risk Analysis & Fast Entry High Yield Tips - nchmf.gov.vn
Is Daxor Corporation stock a buy before product launchesPortfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can Daxor Corporation (DX5) stock retain market dominance2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Chart overlay techniques for tracking Daxor Corporation2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Sector ETF performance correlation with Daxor CorporationWeekly Profit Report & Fast Gaining Stock Reports - newser.com
What earnings revisions data tells us about Daxor Corporation2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Head-To-Head Comparison: Bioqual (OTCMKTS:BIOQ) and Daxor (NASDAQ:DXR) - Defense World
Is Daxor Corporation reversing from oversold territory2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Is Daxor Corporation stock poised for growthExit Point & Weekly Watchlist for Hot Stocks - newser.com
Can Daxor Corporation stock beat analyst upgradesPortfolio Value Summary & Weekly Return Optimization Plans - nchmf.gov.vn
Quarterly Risk: Is Daxor Corporation (DX5) stock undervalued by metricsWeekly Trend Recap & Safe Entry Trade Reports - nchmf.gov.vn
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference - MSN
Using data filters to optimize entry into Daxor CorporationIPO Watch & High Return Stock Watch Alerts - newser.com
Full technical analysis of Daxor Corporation stockDividend Hike & Weekly High Return Stock Forecasts - newser.com
Daxor (DXR) to Showcase at Cardiovascular Conference in Austin - GuruFocus
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 - GlobeNewswire
Next‑Gen BVA System: Daxor Debuts Blood‑Volume Diagnostic at MedAxiom CV Transforum Oct 16–18 - Stock Titan
[N-CSR/A] – DAXOR CORP (DXR) (CIK 0000027367) | DXR SEC FilingForm N-CSR/A - Stock Titan
Using fundamentals and technicals on Daxor CorporationJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Can Daxor Corporation stock sustain free cash flow growthJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Daxor Corporation Azioni (DXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.50%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):